Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia Using Syde®
The study aims to identify which Syde®-derived digital outcomes are reliable in FGFR3-related Skeletal Dysplasia. This requires to set-up a natural history study to measure limb movements in patients with ACH or HCH.
• a. Aged 2 years old or older at the time of consent (France and Belgium)
⁃ b. Aged between 2 years old and \< 17 years old at the time of consent (United Kingdom)
⁃ Written informed consent obtained:
∙ From the parent(s) or legal guardian(s) for participants under 18 years old.
‣ From participants 18 years old and older.
⁃ Affiliated to, or beneficiary of a social security category (not applicable for the United Kingdom)
⁃ Able to walk unassisted for at least 10 meters.
⁃ Genetically confirmed diagnosis with one pathogenic variant (ACMG class IV \& V) of achondroplasia or hypochondroplasia.
⁃ Participant (and caregivers for participants under 18 years old) willing and able to comply with all study procedures including: questionnaires, Syde® related procedures